Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 107


Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014-2015 outbreak.

Edwards T, Semple MG, De Weggheleire A, Claeys Y, De Crop M, Menten J, Ravinetto R, Temmerman S, Lynen L, Bah EI, Smith PG, van Griensven J; Ebola_Tx Consortium.

Clin Trials. 2016 Jan 14. pii: 1740774515621056. [Epub ahead of print]


Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea.

van Griensven J, Edwards T, de Lamballerie X, Semple MG, Gallian P, Baize S, Horby PW, Raoul H, Magassouba N, Antierens A, Lomas C, Faye O, Sall AA, Fransen K, Buyze J, Ravinetto R, Tiberghien P, Claeys Y, De Crop M, Lynen L, Bah EI, Smith PG, Delamou A, De Weggheleire A, Haba N; Ebola-Tx Consortium.

N Engl J Med. 2016 Jan 7;374(1):33-42. doi: 10.1056/NEJMoa1511812.


Advanced HIV Disease at Enrolment in HIV Care: Trends and Associated Factors over a Ten Year Period in Cambodia.

Pe R, Chim B, Thai S, Lynen L, van Griensven J.

PLoS One. 2015 Nov 25;10(11):e0143320. doi: 10.1371/journal.pone.0143320. eCollection 2015.


Drug assessment in the Ebola virus disease epidemic in west Africa.

Yazdanpanah Y, Horby P, van Griensven J, Mentre F, Nguyen VK, Malvy JM, Dunning J, Sissoko D, Delfraissy JF, Levy Y.

Lancet Infect Dis. 2015 Nov;15(11):1258. doi: 10.1016/S1473-3099(15)00344-8. No abstract available.


Ebola: Europe-Africa research collaborations.

Horby PW, Endzt H, Muyembe-Tamfum JJ, van Griensven J, Gevao S, Goossens H, Malvy JM, Haba NY, Yazdanpanah Y, Olliaro P, Semple C, de Jong M, Delamou A, Lang T, Carson G, Kennedy S.

Lancet Infect Dis. 2015 Nov;15(11):1258-9. doi: 10.1016/S1473-3099(15)00375-8. No abstract available.


Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study.

Diro E, Ritmeijer K, Boelaert M, Alves F, Mohammed R, Abongomera C, Ravinetto R, De Crop M, Fikre H, Adera C, Colebunders R, van Loen H, Menten J, Lynen L, Hailu A, van Griensven J.

PLoS Negl Trop Dis. 2015 Oct 2;9(10):e0004087. doi: 10.1371/journal.pntd.0004087. eCollection 2015 Oct.


Sodium stibogluconate and paromomycin for treating visceral leishmaniasis under routine conditions in eastern Sudan.

Atia AM, Mumina A, Tayler-Smith K, Boulle P, Alcoba G, Elhag MS, Alnour M, Shah S, Chappuis F, van Griensven J, Zachariah R.

Trop Med Int Health. 2015 Dec;20(12):1674-84. doi: 10.1111/tmi.12603. Epub 2015 Nov 11.


Implementation of isoniazid preventive therapy in an HIV clinic in Cambodia: high rates of discontinuation when combined with antiretroviral therapy.

van Griensven J, Choun K, Chim B, Thai S, Lorent N, Lynen L.

Trop Med Int Health. 2015 Dec;20(12):1823-31. doi: 10.1111/tmi.12609. Epub 2015 Oct 19.


Open access for operational research publications from low- and middle-income countries: who pays?

Zachariah R, Kumar AM, Reid AJ, Van den Bergh R, Isaakidis P, Draguez B, Delaunois P, Nagaraja SB, Ramsay A, Reeder JC, Denisiuk O, Ali E, Khogali M, Hinderaker SG, Kosgei RJ, van Griensven J, Quaglio GL, Maher D, Billo NE, Terry RF, Harries AD.

Public Health Action. 2014 Sep 21;4(3):142-4. doi: 10.5588/pha.14.0028.


Fostering interest in research: evaluation of an introductory research seminar at hospitals in rural Rwanda.

Iribagiza MK, Manikuzwe A, Aquino T, Amoroso C, Zachariah R, van Griensven J, Schneider S, Finnegan K, Cortas C, Kamanzi E, Hamon JK, Hedt-Gauthier BL.

Public Health Action. 2014 Dec 21;4(4):271-5. doi: 10.5588/pha.14.0093.


The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field.

van Griensven J, De Weiggheleire A, Delamou A, Smith PG, Edwards T, Vandekerckhove P, Bah EI, Colebunders R, Herve I, Lazaygues C, Haba N, Lynen L.

Clin Infect Dis. 2016 Jan 1;62(1):69-74. doi: 10.1093/cid/civ680. Epub 2015 Aug 10.


Procurement and Supply Management System for MDR-TB in Nigeria: Are the Early Warning Targets for Drug Stock Outs and Over Stock of Drugs Being Achieved?

Jatau B, Avong Y, Ogundahunsi O, Shah S, Tayler Smith K, Van den Bergh R, Zachariah R, van Griensven J, Ekong E, Dakum P.

PLoS One. 2015 Jun 22;10(6):e0128500. doi: 10.1371/journal.pone.0128500. eCollection 2015.


Impact of the use of a rapid diagnostic test for visceral leishmaniasis on clinical practice in Ethiopia: a retrospective study.

Diro E, Lynen L, Assefa M, Takele Y, Mengesha B, Adem E, Mohammed R, Kimutai R, Hailu A, Boelaert M, van Griensven J.

PLoS Negl Trop Dis. 2015 May 12;9(5):e0003738. doi: 10.1371/journal.pntd.0003738. eCollection 2015 May.


Ebola: better protection needed for Guinean health-care workers.

Delamou A, Beavogui AH, Kondé MK, van Griensven J, De Brouwere V.

Lancet. 2015 Feb 7;385(9967):503-4. doi: 10.1016/S0140-6736(15)60193-3. No abstract available.


Blood as medicine: social meanings of blood and the success of Ebola trials.

Bannister-Tyrrell M, Gryseels C, Delamou A, D'Alessandro U, van Griensven J, Grietens KP; Ebola_Tx Trial Platform.

Lancet. 2015 Jan 31;385(9966):420. doi: 10.1016/S0140-6736(14)62392-8. Epub 2015 Jan 19. No abstract available.


Picking up the bill - improving health-care utilisation in the Democratic Republic of Congo through user fee subsidisation: a before and after study.

Maini R, Van den Bergh R, van Griensven J, Tayler-Smith K, Ousley J, Carter D, Mhatre S, Ho L, Zachariah R.

BMC Health Serv Res. 2014 Nov 5;14:504. doi: 10.1186/s12913-014-0504-6.


Clinical aspects of paediatric visceral leishmaniasis in North-west Ethiopia.

Diro E, Lynen L, Gebregziabiher B, Assefa A, Lakew W, Belew Z, Hailu A, Boelaert M, van Griensven J.

Trop Med Int Health. 2015 Jan;20(1):8-16. doi: 10.1111/tmi.12407. Epub 2014 Oct 20.


Atypical manifestations of visceral leishmaniasis in patients with HIV in north Ethiopia: a gap in guidelines for the management of opportunistic infections in resource poor settings.

Diro E, van Griensven J, Mohammed R, Colebunders R, Asefa M, Hailu A, Lynen L.

Lancet Infect Dis. 2015 Jan;15(1):122-9. doi: 10.1016/S1473-3099(14)70833-3. Epub 2014 Oct 7.


Visceral leishmaniasis relapse in HIV patients--a role for myeloid-derived suppressor cells?

Van den Bergh R, Van Ginderachter JA, Schouppe E, Desimmie BA, Hailu A, De Baetselier P, van Griensven J.

PLoS Negl Trop Dis. 2014 Sep 11;8(9):e3132. doi: 10.1371/journal.pntd.0003132. eCollection 2014 Sep. No abstract available.


Visceral leishmaniasis and HIV coinfection: time for concerted action.

van Griensven J, Zijlstra EE, Hailu A.

PLoS Negl Trop Dis. 2014 Aug 28;8(8):e3023. doi: 10.1371/journal.pntd.0003023. eCollection 2014 Aug. No abstract available.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk